Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 0: clinchem.2007.089334v1, 2007; 10.1373/clinchem.2007.089334
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2007.089334v1
53/9/1623    most recent
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leaños-Miranda, A.
Right arrow Articles by Ulloa-Aguirre, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leaños-Miranda, A.
Right arrow Articles by Ulloa-Aguirre, A.

Received on March 25, 2007
Accepted on July 2, 2007

Evidence-based Medicine and Test Utilization

Protein:Creatinine Ratio in Random Urine Samples Is a Reliable Marker of Increased 24-Hour Protein Excretion in Hospitalized Women with Hypertensive Disorders of Pregnancy

Alfredo Leaños-Miranda 1*, Janeth Márquez-Acosta 1, Fernando Romero-Arauz 2, Guadalupe M. Cárdenas-Mondragón 1, Roxana Rivera-Leaños 1, Irma Isordia-Salas 1, Alfredo Ulloa-Aguirre 1

1 Research Unit in Reproductive Medicine, México, D.F. México
2 Department of Hypertensive Diseases of Pregnancy Clinic, Hospital de Ginecología y Obstetricia "Luis Castelazo Ayala", Instituto Mexicano del Seguro Social, México, D.F. México

* To whom correspondence should be addressed. E-mail: alfredolm{at}yahoo.com.

Background: The protein:creatinine ratio in random, untimed urine samples correlates with 24-h protein excretion in pregnant women with and without hypertension. Nevertheless, whether this ratio is appropriate as a screening test for proteinuria is still unclear, in part because of the paucity of large studies.

Methods: We measured protein:creatinine ratios in random urine samples and protein contents of 24-h urine samples in a cross-sectional study of 927 hospitalized pregnant women at ≥20-weeks of gestational age and in a 2nd cohort of 161 pregnant women. In the 2nd group, urine specimens were obtained before and after completion of the 24-h collections, avoiding 1st-morning void specimens.

Results: Protein excretion was ≥300 mg/24 h in 282 patients (30.4%). The urine protein:creatinine ratio and the 24-h protein excretion were significantly correlated (r = 0.98, P <0.001). The protein:creatinine ratio as an indicator of protein excretion >300 mg/24 h was ≥0.3. The sensitivity and specificity were 98.2% and 98.8%, respectively. Positive and negative predictive values were 97.2% and 99.2%, respectively, and positive and negative likelihood ratios were 79.2 and 0.02, respectively. The diagnostic accuracy of the urinary protein:creatinine ratio was corroborated in the 2nd cohort of patients, which also showed no statistically significant difference in protein:creatinine ratio between samples obtained >24 h apart.

Conclusions: Random urinary protein:creatinine ratio is a reliable indicator of significant proteinuria (>300 mg/day) in nonambulatory pregnant women, irrespective of sampling time during the daytime. The protein:creatinine ratio may be reasonably used as an alternative to the 24-h urine collection method.




The following articles in journals at HighWire Press have cited this article:


Home page
Obstet GynecolHome page
R. Papanna, L. K. Mann, R. W. Kouides, and J. C. Glantz
Protein/Creatinine Ratio in Preeclampsia: A Systematic Review
Obstet. Gynecol., July 1, 2008; 112(1): 135 - 144.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Leanos-Miranda, J. Marquez-Acosta, G. M. Cardenas-Mondragon, Z. L. Chinolla-Arellano, R. Rivera-Leanos, S. Bermejo-Huerta, J. F. Romero-Arauz, G. Alvarez-Jimenez, J. C. Ramos-Leon, and A. Ulloa-Aguirre
Urinary Prolactin as a Reliable Marker for Preeclampsia, Its Severity, and the Occurrence of Adverse Pregnancy Outcomes
J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2492 - 2499.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2007 by the American Association for Clinical Chemistry.